Oruka Therapeutics (ORKA) Return on Capital Employed (QoQ) (2011 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -450.00 |
| Mar 31, 2024 | -310.00 |
| Dec 31, 2023 | -73.00 |
| Sep 30, 2023 | 115.00 |
| Jun 30, 2023 | 238.00 |
| Mar 31, 2023 | 264.00 |
| Dec 31, 2022 | 832.00 |
| Sep 30, 2022 | 311.00 |
| Jun 30, 2022 | 70.00 |
| Mar 31, 2022 | -107.00 |
| Dec 31, 2021 | -425.00 |
| Sep 30, 2021 | -626.00 |
| Jun 30, 2021 | -325.00 |
| Mar 31, 2021 | -154.00 |
| Dec 31, 2020 | -93.00 |
| Sep 30, 2020 | 4,342.00 |
| Jun 30, 2020 | 1,555.00 |
| Mar 31, 2020 | -860.00 |
| Dec 31, 2019 | -7,422.00 |
| Sep 30, 2019 | 463.00 |
| Jun 30, 2019 | 1,017.00 |
| Mar 31, 2019 | 1,386.00 |
| Dec 31, 2018 | -4,293.00 |
| Sep 30, 2018 | 3,088.00 |
| Jun 30, 2018 | 3,079.00 |
| Mar 31, 2018 | 691.00 |
| Dec 31, 2017 | 7,845.00 |
| Sep 30, 2017 | -1,310.00 |
| Jun 30, 2017 | -2,911.00 |
| Mar 31, 2017 | -1,775.00 |
| Dec 31, 2016 | -1,411.00 |
| Sep 30, 2016 | -1,326.00 |
| Jun 30, 2016 | -663.00 |
| Mar 31, 2016 | -546.00 |
| Dec 31, 2015 | -336.00 |
| Sep 30, 2015 | 1,157.00 |
| Jun 30, 2015 | 3,685.00 |
| Mar 31, 2015 | -1,233.00 |
| Dec 31, 2014 | -740.00 |
| Sep 30, 2014 | -789.00 |
| Jun 30, 2014 | -240.00 |
| Mar 31, 2014 | -227.00 |
| Dec 31, 2013 | -3,123.00 |
| Sep 30, 2013 | -7.00 |
| Jun 30, 2013 | 3,078.00 |
| Mar 31, 2013 | 857.00 |
| Dec 31, 2012 | 10,266.00 |
| Sep 30, 2012 | 319.00 |
| Jun 30, 2012 | -2,785.00 |
| Mar 31, 2012 | 28.00 |
| Dec 31, 2011 | -1,065.00 |